Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS) [Phase 3]

View source ↗

Summary

A Phase 3 study to evaluate the efficacy and safety of drug candidate 608 in adults with active ankylosing spondylitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• 608

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Ankylosing Spondylitis | Phase 3 | Status: RECRUITING